Matthew Lynch

Dr. Matthew Lynch


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2015 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
AOA. O’lEary
A. O’lEary
CUC. Usher
C. Usher
MLMatthew Lynch
Matthew Lynch
MHM. Hall
M. Hall
LHL. Hemeryk
L. Hemeryk
MBM. Barry
M. Barry
The Health (Pricing and Supply of Medical Goods) Act 2013 passed into law in July 2013 and legislated for generic substitution in Ireland. The aim of the study was to ascertain the knowledge and perceptions of stakeholders i.e. patients, pharmacists and prescribers, of generic medicines and to generic substitution with the passing of legislation. Three stakeholder specific questionnaires were developed to assess knowledge of and perceptions to generic medicines and generic substitution. Purposive samples of patients, prescribers and pharmacists were analysed. Descriptive quantitative and qualitative analyses were undertaken. A total of 762 healthcare professionals and 353 patients were recruited. The study highlighted that over 84 % of patients were familiar with generic medicines and are supportive of the concept of generic substitution. Approximately 74 % of prescribers and 84 % of pharmacists were supportive of generic substitution in most cases. The main areas of concern highlighted by the healthcare professionals that might impact on the successful implementation of the policy, were the issue of bioequivalence with generic medicines, the computer software systems used at present in general practitioner (GP) surgeries and the availability of branded generics. The findings from this study identify a high baseline rate of acceptance to generic medicines and generic substitution among patients, prescribers and pharmacists in the Irish setting. The concerns of the main stakeholders provide a valuable insight into the potential difficulties that may arise in its implementation, and the need for on-going reassurance and proactive dissemination of the impact of the generic substitution policy. The existing positive attitude to generic medicines and generic substitution among key stakeholders in Ireland to generic substitution, combined with appropriate support and collaboration should result in the desired increase in rates of prescribing, dispensing and use of generic medicines.

9 September 2023 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
MLMatthew Lynch
Matthew Lynch
AOAisling C. O'LEary
Aisling C. O'LEary
Shortages in healthcare workers affects the overall delivery and effectiveness of the provision of healthcare. There are currently insufficient pharmacists working in the community sector in Ireland. While several studies have reported on the factors leading to retention in the medical and nursing profession, there is an absence of robust research examining retention within the pharmacist workforce in Ireland. To identify and understand the range of factors currently at play in the community pharmacy sector in Ireland which influence the decision-making process for pharmacists deciding whether or not to continue to practice as a community pharmacist. A cross-sectional qualitative descriptive study was used to investigate the factors influencing community pharmacist retention as elicited from the lived experiences of 23 pharmacists. Study recruitment was undertaken using both convenience and purposive sampling. Qualitative content analysis was used to analyze the interview data to identify and explore themes. A broad and diverse range of factors were identified as affecting community pharmacist retention including working conditions, career fulfilment and progression, regulatory and administrative burden, the commercial focus within community practice, lack of representation and their overall health and well-being. The findings show that there are a number of factors which either individually or cumulatively influence a pharmacist's decision to stay in or leave community practice. Various areas for change were identified, which if addressed are considered likely to improve retention in the sector. These include enhanced terms and working conditions, better acknowledgement and resourcing of professional activities, improved opportunities for career progression, reforms to the regulatory model including the personal accountability of a supervising pharmacist for all of the pharmacy's professional activities, a more streamlined model of reimbursement and more effective collective representation.

1 January 2021 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
MLMatthew Lynch
Matthew Lynch
AOAisling C. O'LEary
Aisling C. O'LEary

23 January 2026 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
MBMounyah Basil
Mounyah Basil
WAWaad Ahmed
Waad Ahmed
RHReem Hajeomar
Reem Hajeomar
JSJudith Strawbridge
Judith Strawbridge
MLMatthew Lynch
Matthew Lynch
BMBanan Mukhalalati
Banan Mukhalalati
Background: Generative Artificial Intelligence (GenAI) is one of the leading innovations that is expected to reshape society for decades to come. Health professions education (HPE) programs are expected to prepare graduates with adequate knowledge and skills to provide high-quality patient-centered care. Although the use of GenAI in health professions is increasing, its optimal integration in HPE is still ambiguous. This scoping review aims to synthesize currently available literature regarding the use of GenAI in health professions education. Method: This scoping review is conducted following JBI methodology for scoping reviews framework 2020 and aligned with PRISMA-ScR. A systematic and comprehensive search was conducted in PubMed, ERIC, CINAHL, Embase, Scopus, Cochrane Library, and ProQuest Central with no language restrictions. The identified evidence was screened and extracted using Covidence software. Publications on the integration of GenAI in undergraduate or graduate health profession education were considered. Data was analyzed and presented using graphs and charts. Followed by a narrative thematic mapping of the included studies. Results: Out of 14,208 scanned records, 241 were considered eligible. The included studies discuss the application of GenAI in diverse education processes of different health professions, such as curriculum design, content creation, content delivery, personalized learning, assessment, evaluation, and feedback provision. Most studies focused on ChatGPT integration in medical and nursing education, with content creation emerging as the predominant area of integration, whereas curriculum design and GenAI literacy were underexplored. Perception studies reported a positive perspective regarding GenAI used in education among students and faculty. Conclusion: This review provides an overview of the current integration of GenAI in HPE in the literature, highlighting the associated opportunities, challenges, facilitators, and barriers. Future education efforts should focus on enhancing GenAI literacy, developing policy, and adopting a balanced approach. In addition to conducting comparative studies and long-term assessment of GenAI impact.

1 February 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
MLMatthew Lynch
Matthew Lynch
NKNaonori Kodate
Naonori Kodate

29 October 2022 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
PDF file
MLMatthew Lynch
Matthew Lynch
NKNaonori Kodate
Naonori Kodate
CHConor Hickey
Conor Hickey
AOAisling C. O’lEary
Aisling C. O’lEary
Background: Reforms to models of health and care regulation internationally have adapted to address the challenges associated with regulating healthcare professionals. Pharmacists in Ireland entered a new era of regulation with the enactment of the Pharmacy Act in 2007 which significantly updated the law regulating pharmacy in Ireland and expanded the regulatory scope considerably. An earlier study in 2017 examined the experiences of 20 community pharmacists of the Act. This follow-up study aimed to expand the scope of the original study to all community pharmacists in Ireland, to report their “lived experience” of the regulatory model introduced by the Act, assessing its impact on their professional practice using the principles of “better regulation”. Methods: Survey methodology was used to assess the perception of all community pharmacists registered with the Pharmaceutical Society of Ireland of the Act, as implemented, on their practice using an experimental design based on the seven principles of “Better Regulation”. Descriptive statistics analyzed quantitative responses while answers from open-ended questions were analyzed using a combination of a modified framework analysis and a qualitative content analysis. Results: Respondents agreed that the Act was necessary, although its implementation by the regulator was largely not viewed as fulfilling the remaining “Better Regulation” principles of being effective, proportional, consistent, agile, accountable and transparent. In particular, its proportionality was questioned. This resulted in pharmacists perceiving that their professional competency to act in the best interests of their patients was not appropriately acknowledged by the regulator, which in turn compromised their ability to provide optimal care for their patients. Conclusion: While healthcare professional regulation must primarily be concerned with public protection, it must also have regard to its impact on those delivering healthcare services. The findings highlight the challenge internationally of balancing rigidity and flexibility in professional health and care regulation, and the importance of a regulatory conversation occurring between those regulating and those regulated. This would serve to promote mutual learning and understanding to create a responsive approach to regulation, underpinned by mutual trust, effective risk assessment and adherence to the principles of “Better Regulation”.